Skip to main content

Advertisement

  • Poster presentation
  • Open Access
  • The use of placebo in randomised surgical clinical trials

    • 1,
    • 1, 2,
    • 1,
    • 1,
    • 3,
    • 1 and
    • 1
    Trials201314 (Suppl 1) :P38

    https://doi.org/10.1186/1745-6215-14-S1-P38

    • Published:

    Keywords

    • Placebo
    • Randomise Trial
    • Active Treatment
    • Placebo Effect
    • Placebo Intervention

    Background

    Placebo has an established role in pharmacological trials but is rarely used to examine the efficacy of surgical interventions. The aim of this study was to analyse the efficacy of the crucial surgical element in comparison to the placebo arm in randomised trials investigating surgical procedures.

    Methods

    We searched MEDLINE, EMBASE, and the Cochrane Controlled Trials Register, from their beginning to September 2012, and screened the references of the already included studies. We reviewed randomised clinical trials comparing surgery with a placebo intervention. Surgery was defined as any procedure that changes the anatomy and requires a skin incision or the use of endoscopic techniques; dental studies were excluded. We did not limit the search to any particular type of intervention or condition.

    Results

    We identified 96 relevant reports corresponding to 74 unique studies. Fifty-two trials were included into the meta-analysis. In three quarters of the studies (38/52) an improvement was reported in both arms and only in half of the trials (25/52) the active treatment was more effective than the placebo. The effect was generally in favour of the active treatment but in many trials the difference was statistically significant only for some outcomes.

    Conclusions

    Placebo-controlled randomised trials have a significant value in assessing the absolute efficacy of surgery, especially when the outcomes are subjective and the likelihood of a placebo effect is high. Interventions that are truly effective and superior to placebo should be encouraged and the procedures that are not more effective than placebo should not be performed.

    Authors’ Affiliations

    (1)
    Nuffield Department Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, UK
    (2)
    MRC Lifecourse Epidemiology Unit, Southampton, UK
    (3)
    Oxford Uehiro Centre for Practical Ethics, Oxford, UK

    Copyright

    © Wartolowska et al; licensee BioMed Central Ltd. 2013

    Comments

    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

    Advertisement